Duchenne Muscular Dystrophy Transcriptomic Profiling Market Innovations in Next-Generation Sequencing
The global Duchenne Muscular Dystrophy (DMD) Transcriptomic Profiling Market is set for strong growth, expanding from USD 816.8 million in 2026 to USD 2,277.8 million by 2036 at a 10.8% CAGR. Accelerated by the expansion of gene therapies, RNA biomarker discovery, and exon-skipping platforms, transcriptomic tools are becoming indispensable in DMD research and...
0 Комментарии 0 Поделились 767 Просмотры 0 предпросмотр
Urh Social https://urh.app